Foresight Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.7M Sell
43,414
-5,240
-11% -$2.52M 3.9% 6
2026
Q1
$23.9M Sell
48,654
-2,229
-4% -$1.21M 4.22% 7
2025
Q4
$29.7M Sell
50,883
-903
-2% -$511K 4.47% 4
2025
Q3
$25.1M Sell
51,786
-607
-1% -$283K 3.75% 9
2025
Q2
$21.2M Sell
52,393
-6,104
-10% -$2.55M 3.01% 13
2025
Q1
$29.1M Buy
58,497
+56,747
+3,243% +$30.7M 4.1% 9
2024
Q4
$908K Buy
1,750
+534
+44% +$294K 0.14% 23
2024
Q3
$557K Buy
1,216
+747
+159% +$442K 1.07% 30
2024
Q2
$204K Buy
+469
New +$269K 0.11% 33

Other funds holding TMO

Foresight Group's TMO Position: Q2 2026 in Review

Foresight Group reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $2.52M and leaving 43,414 shares worth $21.7M. The position accounts for 3.9% of the portfolio, ranked #6.

Foresight Group first reported a position in TMO in Q2 2024 and has held it in 9 quarters since. The position peaked at $29.7M in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Foresight Group held 43,414 shares of Thermo Fisher Scientific worth $21.7M as of Q2 2026.
  • Foresight Group sold 5,240 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.52M.
  • Thermo Fisher Scientific made up 3.9% of Foresight Group's portfolio in Q2 2026, its #6 holding.
  • Foresight Group first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 9 quarters since.
  • Foresight Group's Thermo Fisher Scientific position peaked at $29.7M in Q4 2025.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Foresight Group's 13F filing for Q2 2026, filed 27 Jul 2026.